Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1
Authors:
- Vicki HuffVHVicki Huff
- Jerry PelletierJPJerry Pelletier
- 1 November 1993
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 123 (5) , 673-678
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys— Drash syndromeHuman Molecular Genetics, 1993
- Constitutional mutations in the WT1 gene in patients with Denys-Drash syndromeHuman Molecular Genetics, 1992
- Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital developmentNature Genetics, 1992
- Androgen Resistance — The Clinical and Molecular SpectrumNew England Journal of Medicine, 1992
- Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndromeCell, 1991
- Wilms Tumor Locus on 11p13 Defined by Multiple CpG Island-Associated TranscriptsScience, 1990
- Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome)The Journal of Pediatrics, 1990
- Pseudohermaphroditism, glomerulopathy, and Wilms tumor (Drash syndrome)The Journal of Pediatrics, 1985
- Pseudohermaphroditism, glomerulopathy, and Wilms tumor (Drash syndrome): Frequency in end-stage renal failureThe Journal of Pediatrics, 1985
- A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal diseaseThe Journal of Pediatrics, 1970